Driton Vela

594 total citations
15 papers, 429 citations indexed

About

Driton Vela is a scholar working on Hematology, Nutrition and Dietetics and Genetics. According to data from OpenAlex, Driton Vela has authored 15 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 6 papers in Nutrition and Dietetics and 5 papers in Genetics. Recurrent topics in Driton Vela's work include Iron Metabolism and Disorders (10 papers), Erythropoietin and Anemia Treatment (7 papers) and Trace Elements in Health (5 papers). Driton Vela is often cited by papers focused on Iron Metabolism and Disorders (10 papers), Erythropoietin and Anemia Treatment (7 papers) and Trace Elements in Health (5 papers). Driton Vela collaborates with scholars based in Kosovo, North Macedonia and Poland. Driton Vela's co-authors include Mitko Mladenov, Mjellma Rexhepi, Bonell Patiño-Escobar, Roberto Méndez‐Gallart, Gani Bajraktari, Elizabeta Gjorgievska, Artan Ahmeti, Arlind Batalli, Michael Y. Henein and Afrim Poniku and has published in prestigious journals such as British Journal of Clinical Pharmacology, Frontiers in Neuroscience and Advances in experimental medicine and biology.

In The Last Decade

Driton Vela

15 papers receiving 424 citations

Peers

Countries citing papers authored by Driton Vela

Since Specialization

Citations

This map shows the geographic impact of Driton Vela's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Driton Vela with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Driton Vela more than expected).

Fields of papers citing papers by Driton Vela

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Driton Vela. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Driton Vela. The network helps show where Driton Vela may publish in the future.

Co-authorship network of co-authors of Driton Vela

This figure shows the co-authorship network connecting the top 25 collaborators of Driton Vela. A scholar is included among the top collaborators of Driton Vela based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Driton Vela. Driton Vela is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Title	Journal	Authors	Indexed citations
1	Efficacy and safety of tocilizumab versus standard care/placebo in patients with COVID‐19; a systematic review and meta‐analysis of randomized clinical trials	British Journal of Clinical Pharmacology	Driton Vela, Mjellma Rexhepi et al.	22
2	Iron in the Tumor Microenvironment	Advances in experimental medicine and biology	Driton Vela	15
3	Keeping heart homeostasis in check through the balance of iron metabolism	Acta Physiologica	Driton Vela	36
4	Differential regulation of hepcidin in cancer and non-cancer tissues and its clinical implications	Experimental & Molecular Medicine	Driton Vela et al.	63
5	Low hepcidin in liver fibrosis and cirrhosis; a tale of progressive disorder and a case for a new biochemical marker	Molecular Medicine	Driton Vela	45
6	Hepcidin, an emerging and important player in brain iron homeostasis	Journal of Translational Medicine	Driton Vela	82
7	Systemic and local hepcidin as emerging and important peptides in renal homeostasis and pathology	BioFactors	Driton Vela	3
8	The Dual Role of Hepcidin in Brain Iron Load and Inflammation	Frontiers in Neuroscience	Driton Vela	53
9	Iron Metabolism in Prostate Cancer; From Basic Science to New Therapeutic Strategies	Frontiers in Oncology	Driton Vela	29
10	Insulin treatment corrects hepcidin but not YKL-40 levels in persons with type 2 diabetes mellitus matched by body mass index, waist-to-height ratio, C-reactive protein and Creatinine	BMC Endocrine Disorders	Driton Vela, Mitko Mladenov et al.	5
11	Balance of cardiac and systemic hepcidin and its role in heart physiology and pathology	Laboratory Investigation	Driton Vela	32
12	Low Hepcidin in Type 2 Diabetes Mellitus: Examining the Molecular Links and Their Clinical Implications	Canadian Journal of Diabetes	Driton Vela, Mitko Mladenov et al.	11
13	The Role of Insulin Therapy in Correcting Hepcidin Levels in Patients with Type 2 Diabetes Mellitus	Oman Medical Journal	Driton Vela, Elizabeta Gjorgievska et al.	8
14	Left ventricular markers of global dyssynchrony predict limited exercise capacity in heart failure, but not in patients with preserved ejection fraction	Cardiovascular Ultrasound	Gani Bajraktari, Arlind Batalli et al.	14
15	[Platelet-rich plasma (platelet gel) in secondary alveoloplasty in cleft patients].	PubMed	Roberto Méndez‐Gallart, Bonell Patiño-Escobar et al.	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact